Accumulated β-catenin enters the nucleus and binds to TCF transcription factors to activate the transcription of downstream genes including CD44, MYC and LGR5, which potentiate the stemness of CRC and promotes CRC progression [9–11]. The gene discussed is MYC; the disease is colorectal carcinoma.